Cargando…
Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion
BACKGROUND: Tuberculosis (TB) remains a major public health concern on a global scale, especially in developing nations. So far, no formal guidelines are available for the diagnosis and treatment of tuberculosis pleurisy. The diagnosis of TB is worsened by the immense difficulty in differential dete...
Autores principales: | Tang, Yimin, Zhang, Juanjuan, Huang, Huarong, He, Xing, Zhang, Jiaohong, Ou, Min, Li, Guobao, Zeng, Changchun, Ye, Taosheng, Ren, Lili, Liu, Yingxia, Zhang, Guoliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335673/ https://www.ncbi.nlm.nih.gov/pubmed/30651075 http://dx.doi.org/10.1186/s12879-018-3654-z |
Ejemplares similares
-
Distinguishing tuberculosis pleural effusion from parasitic pleural effusion using pleural fluid characteristics: A case control study
por: Tong, Shuai, et al.
Publicado: (2019) -
GC‐MS metabolomics identifies novel biomarkers to distinguish tuberculosis pleural effusion from malignant pleural effusion
por: Liu, Yongxia, et al.
Publicado: (2021) -
A novel biomarker for pleural effusion diagnosis: Interleukin‐36γ in pleural fluid
por: Guo, Lun, et al.
Publicado: (2022) -
Ferritin Assay in Malignant Pleural Effusion
por: Chung, Won-Tae, et al.
Publicado: (1987) -
The value of apolipoprotein E in distinguishing benign and malignant unilateral pleural effusions
por: Xue, Qing, et al.
Publicado: (2020)